Skip to main content

and
  1. No Access

    Article

    Advances in local therapy for glioblastoma — taking the fight to the tumour

    Despite advances in neurosurgery, chemotherapy and radiotherapy, glioblastoma remains one of the most treatment-resistant CNS malignancies, and the tumour inevitably recurs. The majority of recurrences appear ...

    Thomas S. van Solinge, Lisa Nieland, E. Antonio Chiocca in Nature Reviews Neurology (2022)

  2. No Access

    Chapter

    Local Therapies

    Local therapies in the context of cranial tumor encompass the concept of local application or local delivery, respectively. Apart from surgical resection which is the most obvious form of local therapy, radiat...

    Rachel Grossmann, Zvi Ram, Michael A. Vogelbaum in Oncology of CNS Tumors (2019)

  3. No Access

    Article

    Viruses in cancer therapy — from benchwarmers to quarterbacks

    A recent clinical trial of a virotherapy approach, consisting of an engineered poliovirus, has provided evidence of apparently durable responses in patients with recurrent glioblastoma. The results of this tri...

    Pierpaolo Peruzzi, E. Antonio Chiocca in Nature Reviews Clinical Oncology (2018)

  4. No Access

    Article

    Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone

    While salvage re-irradiation is often used for recurrent high-grade glioma (HGG), there have been few comparisons between various re-radiation dose/fractionation schedules or with bevacizumab alone. We analyze...

    Nils D. Arvold, Diana D. Shi, Ayal A. Aizer, Andrew D. Norden in Journal of Neuro-Oncology (2017)

  5. No Access

    Article

    Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation

    Despite a high symptom burden, little is known about the incidence or predictors of hospitalization among glioblastoma patients, including risks during chemoradiation (CRT). We studied 196 consecutive newly d...

    Rifaquat Rahman, Paul J. Catalano, David A. Reardon in Journal of Neuro-Oncology (2015)

  6. No Access

    Article

    Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma

    We have established a pair of animal models (J3T-1 and J3T-2) with different invasive and angiogenic phenotypes, and demonstrated that annexin A2 is expressed at higher levels in J3T-1 than J3T-2 cells. The fu...

    Manabu Onishi, Tomotsugu Ichikawa, Kazuhiko Kurozumi in Brain Tumor Pathology (2015)

  7. No Access

    Protocol

    Modification of HSV-1 to an Oncolytic Virus

    Cancer-permissive viruses or oncolytic viruses consist of either genetically engineered or naturally occurring strains that possess relatively selective replicative and/or infection abilities for cancer vs. no...

    Hiroshi Nakashima, E. Antonio Chiocca in Herpes Simplex Virus (2014)

  8. No Access

    Chapter

    Intraoperative MRI (ioMRI) in the Setting of Awake Craniotomies for Supratentorial Glioma Resection

    Both awake craniotomy under conscious sedation and use of intraoperative MRI can increase the efficiency and safety of glioma resections. In contrast to craniotomies under general anesthesia, neurosurgery unde...

    Pierpaolo Peruzzi, Erika Puente, Sergio Bergese in Intraoperative Imaging (2011)

  9. No Access

    Article

    Emerging functions of microRNAs in glioblastoma

    Distinct patterns of microRNA expression have been observed in glioblastomas. The functional significance of some of these microRNAs is beginning to emerge. This data indicates that microRNAs play roles in mul...

    Sean Lawler, E. Antonio Chiocca in Journal of Neuro-Oncology (2009)

  10. No Access

    Article

    Modeling the effects of resection, radiation and chemotherapy in glioblastoma

    The standard treatment for newly diagnosed glioblastoma multiforme is surgical resection followed by radiotherapy and chemotherapy. Most studies on these treatments are retrospective clinical data analysis. To...

    Jianjun Paul Tian, Avner Friedman, ** Wang in Journal of Neuro-Oncology (2009)

  11. No Access

    Article

    C2/C3 pathologic fractures from polyostotic fibrous dysplasia of the cervical spine treated with percutaneous vertebroplasty

    We will discuss a potential role of percutaneous vertebroplasty (PVP) in the management of patients with severe fibrous dysplasia of the spine with multiple cervical lesions and C2–C3 pathologic fractures that...

    David Dang, Mirza N. Baig, Greg Christoforidis in European Spine Journal (2007)

  12. No Access

    Article

    GNOSIS: Guidelines for Neuro-Oncology: Standards for Investigational Studies — reporting of surgically based therapeutic clinical trials

    We present guidelines to standardize the reporting of surgically based neuro-oncology trials. The guidelines are summarized in a checklist format that can be used as a framework from which to construct a surgi...

    Susan Chang, Michael Vogelbaum, Frederick F. Lang in Journal of Neuro-Oncology (2007)

  13. Article

    Open Access

    Neurosurgical robotics: a review of brain and spine applications

    Neurosurgery has traditionally been at the forefront of advancing technologies, adapting new techniques and devices successfully in an effort to increase the safety and efficacy of brain and spine surgery. Amo...

    Chris S. Karas, E. Antonio Chiocca in Journal of Robotic Surgery (2007)

  14. No Access

    Chapter

    Clinical Trials of Oncolytic Viruses for Gliomas

    There has been resurgent interest in the use of mutant or genetically engineered strains of viruses for the local treatment of gliomas. The clinical status of these agents is reviewed and further progress in t...

    E. Antonio Chiocca, M. L. Lamfers in High-Grade Gliomas (2007)

  15. No Access

    Article

    Neurosurgical Delivery of Chemotherapeutics, Targeted Toxins, Genetic and Viral Therapies in Neuro-Oncology

    Local delivery of biologic agents, such as gene and viruses, has been tested preclinically with encouraging success, and in some instances clinical trials have also been performed. In addition, the positive pr...

    E. Antonio Chiocca, William C. Broaddus, George T. Gillies in Journal of Neuro-Oncology (2004)

  16. No Access

    Article

    The Combination of Adenoviral HSV TK Gene Therapy and Radiation is Effective in Athymic Mouse Glioblastoma Xenografts without Increasing Toxic Side Effects

    Object: In mouse models of prostate and breast cancer therapeutic effects are enhanced when adenoviral HSV TK gene therapy is combined with ionizing radiation. In the present study, we adopted this approach for ...

    Ulf Nestler, Hiroaki Wakimoto, Fernando Siller-Lopez in Journal of Neuro-Oncology (2004)

  17. No Access

    Protocol

    Cytochrome P450-Based Gene Therapies for Cancer

    Cytochrome P450 (CYP) is comprosed of a family of hemeprotein monooxygenases that catalyze reactions as diverse as the biosynthesis of steroid hormones, metabolism of fat-soluble vitamins, oxidation of unsatur...

    E. Antonio Chiocca, David J. Waxman in Suicide Gene Therapy (2004)

  18. No Access

    Article

    Introduction to the issue

    E. Antonio Chiocca in Journal of Neuro-Oncology (2003)

  19. No Access

    Article

    Growth of human acoustic neuromas, neurofibromas and schwannomas in the subrenal capsule and sciatic nerve of the nude mouse

    To develop a reproducible in vivo model for the growth of human acoustic neuromas and neurofibromas, we implanted tumor specimens (6 acoustic neuromas; 4 neurofibromas; 3 schwannomas arising in skin and soft tiss...

    Jung Kyo Lee, Raymond A. Sobel, E. Antonio Chiocca, Tai S. Kim in Journal of Neuro-Oncology (1992)